Pharmacoeconomic studies of atypical antipsychotics: Review and perspective

[1] ADDINGTON DE, 1993, CLIN THER, V15, P917

[2] Cost-effectiveness of clozapine - A UK clinic-based study [J]. BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 : 125 - 130

[3] Reduction of healthcare resource utilisation and costs following the use of risperidone for patients with schizophrenia previously treated with standard antipsychotic therapy - A retrospective analysis using the Saskatchewan Health Linkable Databases [J]. CLINICAL DRUG INVESTIGATION, 1996, 11 (05) : 289 - 299

[4] [Anonymous], ANN CLIN PSYCHIAT

[5] A NEW PATIENT FOCUSED INDEX FOR MEASURING QUALITY-OF-LIFE IN PERSONS WITH SEVERE AND PERSISTENT MENTAL-ILLNESS [J]. QUALITY OF LIFE RESEARCH, 1993, 2 (04) : 239 - 251

[6] Economic and health state utility determinations for schizophrenic patients treated with risperidone or haloperidol [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (04) : 298 - 307

[7] ASSESSMENT OF COSTS AND BENEFITS OF DRUG-THERAPY FOR TREATMENT-RESISTANT SCHIZOPHRENIA IN THE UNITED-KINGDOM [J]. BRITISH JOURNAL OF PSYCHIATRY, 1993, 162 : 38 - 42

[8] Essock SM, 1996, PSYCHOPHARMACOL BULL, V32, P683

[9] GeronimiFerret D, 1997, ENCEPHALE, V23, P24

[10] Glazer WM, 1997, J CLIN PSYCHIAT, V58, P50

[1] ADDINGTON DE, 1993, CLIN THER, V15, P917

[2] Cost-effectiveness of clozapine - A UK clinic-based study [J]. BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 : 125 - 130

[3] Reduction of healthcare resource utilisation and costs following the use of risperidone for patients with schizophrenia previously treated with standard antipsychotic therapy - A retrospective analysis using the Saskatchewan Health Linkable Databases [J]. CLINICAL DRUG INVESTIGATION, 1996, 11 (05) : 289 - 299

[4] [Anonymous], ANN CLIN PSYCHIAT

[5] A NEW PATIENT FOCUSED INDEX FOR MEASURING QUALITY-OF-LIFE IN PERSONS WITH SEVERE AND PERSISTENT MENTAL-ILLNESS [J]. QUALITY OF LIFE RESEARCH, 1993, 2 (04) : 239 - 251

[6] Economic and health state utility determinations for schizophrenic patients treated with risperidone or haloperidol [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (04) : 298 - 307

[7] ASSESSMENT OF COSTS AND BENEFITS OF DRUG-THERAPY FOR TREATMENT-RESISTANT SCHIZOPHRENIA IN THE UNITED-KINGDOM [J]. BRITISH JOURNAL OF PSYCHIATRY, 1993, 162 : 38 - 42

[8] Essock SM, 1996, PSYCHOPHARMACOL BULL, V32, P683

[9] GeronimiFerret D, 1997, ENCEPHALE, V23, P24

[10] Glazer WM, 1997, J CLIN PSYCHIAT, V58, P50